Dow Up 1.32% Nasdaq Up 1.60%

Incyte Corporation (INCY)

-NasdaqGS
54.95 Oct 23, 4:00PM EDT
Prev Close:54.95
Open:N/A
Bid:50.51 x 100
Ask:55.49 x 100
1y Target Est:75.15
Beta:N/A
Next Earnings Date:30-Oct-14INCY Earnings announcement
Day's Range:N/A - N/A
52wk Range:35.21 - 70.86
Volume:0
Avg Vol (3m):951,089
Market Cap:9.25B
P/E (ttm):N/A
EPS (ttm):-0.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for INCY

Comparison

Symbol% ChgMkt Cap
INCY 0.00%9.25B
AMGN111.85B
CELG80.27B
RHHBY249.03B

Key Statistics

Forward P/E (1 yr):219.80
P/S (ttm):24.91
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.39
Quarterly EPS Est (Sep-14) :0.00
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-1.68

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs primarily for oncology and inflammation. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback